Annual Report

Overview

The report records consolidated FY2018 net sales of 52,241 million yen and the launch of a medical and pharmaceuticals segment that generated 819 million yen. It highlights the establishment of Taiyo Pharma and renewable-energy expansion through the Ranzan Onuma Floating Solar Power Plant. The CSR section describes environmental protection, ethical compliance, supplier audits, and community programs.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2018
Period: Ends 31 March 2018
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services